Skip to main content

S Phase Biofund meeting: “VENTURING INTO BIOTECH” WITH JOSH TRANTUM, PHD, MBA, Dec 14, 2023

Posted by on Friday, December 9, 2022 in Announcements .

About S Phase

A student-run evergreen investment fund dedicated to educating graduate students on investing in emerging biotechnology and pharmaceutical companies through investment analysis, experiential portfolio management, bookkeeping and finance modules, and professional networking opportunities, while seeking capital growth.

DEC 14, 2022 | 5 – 6PM CST (ZOOM)


Josh has spent his career in the life science industry in senior leadership roles of operating companies as well as on the investment side in equity research and portfolio management.
Prior to co-founding CUREX in 2019, Josh was a buy-side research analyst covering the biotech and medtech sectors for a firm with approximately $3 billion in assets during his tenure. Josh has previously led pre-clinical drug development for a NASDAQ-listed biopharmaceutical company and co-founded a clinical stage company developing companion diagnostics for cancer immunotherapy. Earlier in his career, Josh worked as a senior biomedical engineer in the medical device industry where he oversaw the development and commercialization of devices that treat life-threatening cardiac arrhythmias. Josh attained his bachelor’s, master’s, and doctorate degrees in biomedical engineering from Vanderbilt University and his MBA from Emory University. He is co-author on papers published in peer-reviewed biomedical journals and is a co-inventor on multiple patents. Josh also currently holds a part-time adjunct appointment as Assistant Professor in the Department of Biomedical Engineering at Vanderbilt University.


After the seminar, join us for a biotech happy hour at Fable Lounge, located at 114 28th Ave N, Nashville, TN 37203. Drinks and hors d’oeuvres will be generously sponsored by the Vanderbilt Quantitative Systems Biology Center! (RSVP required)

Tags: ,